CME Group Files 8-K Report

TL;DR

CME Group filed a routine 8-K on 3/3/25, nothing major to see here.

AI Summary

On March 3, 2025, CME Group Inc. filed an 8-K report to disclose other events and financial statements. The filing does not contain specific details about the nature of these events or financial figures, but it confirms the company's ongoing reporting obligations.

Why It Matters

This filing indicates CME Group is meeting its regulatory reporting requirements, which is standard for publicly traded companies.

Risk Assessment

Risk Level: low — This is a routine regulatory filing with no new material information disclosed.

Key Players & Entities

• CME GROUP INC. (company) — Registrant
• 0001193125-25-045633 (filing_id) — Accession Number
• March 3, 2025 (date) — Date of earliest event reported
• 20 South Wacker Drive, Chicago, Illinois 60606 (address) — Principal Executive Offices

FAQ

From the Filing

0001193125-25-045633.txt : 20250304 0001193125-25-045633.hdr.sgml : 20250304 20250304163001 ACCESSION NUMBER: 0001193125-25-045633 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250303 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250304 DATE AS OF CHANGE: 20250304 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CME GROUP INC. CENTRAL INDEX KEY: 0001156375 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200] ORGANIZATION NAME: 09 Crypto Assets IRS NUMBER: 364459170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31553 FILM NUMBER: 25705095 BUSINESS ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 3129301000 MAIL ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: CHICAGO MERCANTILE EXCHANGE HOLDINGS INC DATE OF NAME CHANGE: 20010802 8-K 1 d830960d8k.htm 8-K 8-K false 0001156375 0001156375 2025-03-03 2025-03-03     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2025     CME GROUP INC. (Exact name of registrant as specified in its charter)       Delaware   001-31553   36-4459170 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   20 South Wacker Drive   Chicago   Illinois    60606 (Address of Principal Executive Offices)        (Zip Code) Registrant’s telephone number, including area code: (312) 930-1000 N/A (Former name or former address, if changed since last report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol   Name of each exchange on which registered Class A Common Stock   CME   Nasdaq Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 8.01 Other Events. On March 3, 2025, CME Group Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) between the Company and Barclays Capital Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the underwriters named therein (together, the “Underwriters”), in connection with the issuance and sale of $750,000,000 aggregate principal amount of the Company’s 4.400% Notes due 2030 in an underwritten public offering. The Underwriting Agreement inc